secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2025-01-10T23:59:59+00:00
Accession:  0001213900-25-002381
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne reports preliminary Q1 FY2025 revenue of $6.2M, up from $1.0M YoY
--------------------------------------------------------------------------

- Preliminary unaudited Q1 FY2025 total revenue $6.2M vs $1.0M in Q1 FY2024.
- Includes $3.0M one-time collaboration revenue from Zimmer Biomet expanded distribution agreement.
- Product revenue $3.2M, up 227% YoY from $1.0M.
- Reiterates FY2025 product revenue guidance $8-10M, product gross margin 47-51%.
- Virtual investor webinar held Jan 10, 2025 at 11am ET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390025002381/0001213900-25-002381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390025002381/ea0225131-8k_neuroone.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-002381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer